This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
|5064-31-3||Na3NTA||Glycine, N,N-bis(carboxymethyl)-, trisodium salt||HTML||Does not meet||None planned at this time|
|December 2021||Anticipated publication of the final screening.|
|December 19, 2020||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 51.|
Report a problem or mistake on this page
- Date modified: